279 related articles for article (PubMed ID: 18081650)
1. Review article: Inflammatory bowel disease and genetics.
Weersma RK; van Dullemen HM; van der Steege G; Nolte IM; Kleibeuker JH; Dijkstra G
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():57-65. PubMed ID: 18081650
[TBL] [Abstract][Full Text] [Related]
2. Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy.
Van Limbergen J; Nimmo ER; Russell RK; Drummond HE; Smith L; Anderson NH; Davies G; Arnott ID; Wilson DC; Satsangi J
Hum Mol Genet; 2007 Sep; 16(18):2175-86. PubMed ID: 17613538
[TBL] [Abstract][Full Text] [Related]
3. NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease.
Figueroa C; Peralta A; Herrera L; Castro P; Gutiérrez A; Valenzuela J; Aguillón JC; Quera R; Hermoso MA
Eur Cytokine Netw; 2006 Jun; 17(2):125-30. PubMed ID: 16840031
[TBL] [Abstract][Full Text] [Related]
4. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
[TBL] [Abstract][Full Text] [Related]
5. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
6. [Inflammatory bowel diseases: an immunological approach].
Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
[TBL] [Abstract][Full Text] [Related]
7. [The genetic basis of inflammatory bowel disease unravelled by genetic association studies].
Visschedijk MC; Festen EA; Wijmenga C; Weersma RK
Ned Tijdschr Geneeskd; 2009; 153():A402. PubMed ID: 19900309
[TBL] [Abstract][Full Text] [Related]
8. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
[TBL] [Abstract][Full Text] [Related]
9. Genetics of inflammatory bowel disease: progress and prospects.
Mathew CG; Lewis CM
Hum Mol Genet; 2004 Apr; 13 Spec No 1():R161-8. PubMed ID: 14764625
[TBL] [Abstract][Full Text] [Related]
10. Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease.
Vermeire S
Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():2-10. PubMed ID: 16961737
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, genes and inflammatory bowel diseases in childhood.
de Mesquita MB; Civitelli F; Levine A
Dig Liver Dis; 2008 Jan; 40(1):3-11. PubMed ID: 17997369
[TBL] [Abstract][Full Text] [Related]
12. TUCAN (CARD8) genetic variants and inflammatory bowel disease.
McGovern DP; Butler H; Ahmad T; Paolucci M; van Heel DA; Negoro K; Hysi P; Ragoussis J; Travis SP; Cardon LR; Jewell DP
Gastroenterology; 2006 Oct; 131(4):1190-6. PubMed ID: 17030188
[TBL] [Abstract][Full Text] [Related]
13. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease.
Baumgart DC; Buning C; Geerdts L; Schmidt HH; Genschel J; Fiedler T; Gentz E; Molnar T; Nagy F; Lonovics J; Lochs H; Wiedenmann B; Nickel R; Witt H; Dignass A
Digestion; 2007; 76(3-4):196-202. PubMed ID: 18174680
[TBL] [Abstract][Full Text] [Related]
14. Advances in the molecular dissection of inflammatory bowel disease.
Siminovitch KA
Semin Immunol; 2006 Aug; 18(4):244-53. PubMed ID: 16679026
[TBL] [Abstract][Full Text] [Related]
15. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease.
McGovern DP; Hysi P; Ahmad T; van Heel DA; Moffatt MF; Carey A; Cookson WO; Jewell DP
Hum Mol Genet; 2005 May; 14(10):1245-50. PubMed ID: 15790594
[TBL] [Abstract][Full Text] [Related]
16. The genetics of inflammatory bowel disease.
Bonen DK; Cho JH
Gastroenterology; 2003 Feb; 124(2):521-36. PubMed ID: 12557156
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease in children: a pediatrician's perspective.
Cuffari C
Minerva Pediatr; 2006 Apr; 58(2):139-57. PubMed ID: 16835574
[TBL] [Abstract][Full Text] [Related]
18. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility genes and overall pathogenesis of inflammatory bowel disease: where do we stand?
Fiocchi C
Dig Dis; 2009; 27(3):226-35. PubMed ID: 19786745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
